肾移植受者中携带CYP2C19基因突变者他克莫司与质子泵抑制剂的药物相互作用 - Suppr

Suppr

超能文献

Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.

作者信息

Itagaki F, Homma M, Yuzawa K, Fukao K, Kohda Y

机构信息

Department of Pharmaceutical Sciences, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.

出版信息

Transplant Proc. 2002 Nov;34(7):2777-8. doi: 10.1016/s0041-1345(02)03409-7.

DOI:10.1016/s0041-1345(02)03409-7

PMID:12431607

Abstract

摘要

相似文献

Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.

Transplant Proc. 2002 Nov;34(7):2777-8. doi: 10.1016/s0041-1345(02)03409-7.

Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation.

Transplantation. 2002 Jan 27;73(2):303-4. doi: 10.1097/00007890-200201270-00028.

Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations.

J Pharm Pharmacol. 2004 Aug;56(8):1055-9. doi: 10.1211/0022357043914.

Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers.

Xenobiotica. 2005 May;35(5):479-86. doi: 10.1080/00498250500111562.

Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients.

Biopharm Drug Dispos. 2007 May;28(4):167-75. doi: 10.1002/bdd.544.

Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism.

Ann Pharmacother. 2004 May;38(5):791-4. doi: 10.1345/aph.1D366. Epub 2004 Mar 9.

CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects.

Pharm Res. 2001 Jun;18(6):721-7. doi: 10.1023/a:1011035007591.

Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation.

Ther Drug Monit. 2008 Feb;30(1):46-51. doi: 10.1097/FTD.0b013e31816337b7.

Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient.

Drug Metab Pharmacokinet. 2007 Dec;22(6):441-4. doi: 10.2133/dmpk.22.441.

Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.

Aliment Pharmacol Ther. 2004 Nov;20 Suppl 6:11-9. doi: 10.1111/j.1365-2036.2004.02161.x.

引用本文的文献

The effect of the use of omeprazole versus famotidine on the kidney transplant function: a randomized controlled study.

Sci Rep. 2025 Jan 13;15(1):1805. doi: 10.1038/s41598-025-85534-w.

Assessment of omeprazole and famotidine effects on the pharmacokinetics of tacrolimus in patients following kidney transplant-randomized controlled trial.

Front Pharmacol. 2024 Apr 4;15:1352323. doi: 10.3389/fphar.2024.1352323. eCollection 2024.

Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.

Clin Pharmacokinet. 2018 Oct;57(10):1267-1293. doi: 10.1007/s40262-018-0650-9.

The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.

Drugs. 2017 Apr;77(5):547-561. doi: 10.1007/s40265-017-0712-6.

Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.

Drug Saf. 2014 Apr;37(4):201-11. doi: 10.1007/s40264-014-0144-0.

The influence of comedication on tacrolimus blood concentration in patients subjected to kidney transplantation: a retrospective study.

Eur J Drug Metab Pharmacokinet. 2014 Dec;39(4):243-53. doi: 10.1007/s13318-013-0168-3. Epub 2013 Dec 20.

Fatal lactic acidosis in a kidney transplant recipient on combination antiretroviral therapy after initiation of tacrolimus therapy.

Case Rep Transplant. 2011;2011:210178. doi: 10.1155/2011/210178. Epub 2012 Jan 5.

Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report.

Int Urol Nephrol. 2012 Dec;44(6):1903-6. doi: 10.1007/s11255-011-9972-3. Epub 2011 May 3.

Drug-drug interaction profiles of proton pump inhibitors.

Clin Pharmacokinet. 2010 Aug;49(8):509-33. doi: 10.2165/11531320-000000000-00000.

Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients.

Ther Clin Risk Manag. 2010 Jun 24;6:265-9. doi: 10.2147/tcrm.s11501.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.

作者信息

Itagaki F, Homma M, Yuzawa K, Fukao K, Kohda Y

机构信息

Department of Pharmaceutical Sciences, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.

出版信息

Transplant Proc. 2002 Nov;34(7):2777-8. doi: 10.1016/s0041-1345(02)03409-7.

DOI:10.1016/s0041-1345(02)03409-7

PMID:12431607

Abstract

摘要

相似文献

Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.

Transplant Proc. 2002 Nov;34(7):2777-8. doi: 10.1016/s0041-1345(02)03409-7.

Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation.

Transplantation. 2002 Jan 27;73(2):303-4. doi: 10.1097/00007890-200201270-00028.

Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations.

J Pharm Pharmacol. 2004 Aug;56(8):1055-9. doi: 10.1211/0022357043914.

Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers.

Xenobiotica. 2005 May;35(5):479-86. doi: 10.1080/00498250500111562.

Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients.

Biopharm Drug Dispos. 2007 May;28(4):167-75. doi: 10.1002/bdd.544.

Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism.

Ann Pharmacother. 2004 May;38(5):791-4. doi: 10.1345/aph.1D366. Epub 2004 Mar 9.

CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects.

Pharm Res. 2001 Jun;18(6):721-7. doi: 10.1023/a:1011035007591.

Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation.

Ther Drug Monit. 2008 Feb;30(1):46-51. doi: 10.1097/FTD.0b013e31816337b7.

Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient.

Drug Metab Pharmacokinet. 2007 Dec;22(6):441-4. doi: 10.2133/dmpk.22.441.

Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.

Aliment Pharmacol Ther. 2004 Nov;20 Suppl 6:11-9. doi: 10.1111/j.1365-2036.2004.02161.x.

引用本文的文献

The effect of the use of omeprazole versus famotidine on the kidney transplant function: a randomized controlled study.

Sci Rep. 2025 Jan 13;15(1):1805. doi: 10.1038/s41598-025-85534-w.

Assessment of omeprazole and famotidine effects on the pharmacokinetics of tacrolimus in patients following kidney transplant-randomized controlled trial.

Front Pharmacol. 2024 Apr 4;15:1352323. doi: 10.3389/fphar.2024.1352323. eCollection 2024.

Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.

Clin Pharmacokinet. 2018 Oct;57(10):1267-1293. doi: 10.1007/s40262-018-0650-9.

The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.

Drugs. 2017 Apr;77(5):547-561. doi: 10.1007/s40265-017-0712-6.

Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.

Drug Saf. 2014 Apr;37(4):201-11. doi: 10.1007/s40264-014-0144-0.

The influence of comedication on tacrolimus blood concentration in patients subjected to kidney transplantation: a retrospective study.

Eur J Drug Metab Pharmacokinet. 2014 Dec;39(4):243-53. doi: 10.1007/s13318-013-0168-3. Epub 2013 Dec 20.

Fatal lactic acidosis in a kidney transplant recipient on combination antiretroviral therapy after initiation of tacrolimus therapy.

Case Rep Transplant. 2011;2011:210178. doi: 10.1155/2011/210178. Epub 2012 Jan 5.

Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report.

Int Urol Nephrol. 2012 Dec;44(6):1903-6. doi: 10.1007/s11255-011-9972-3. Epub 2011 May 3.

Drug-drug interaction profiles of proton pump inhibitors.

Clin Pharmacokinet. 2010 Aug;49(8):509-33. doi: 10.2165/11531320-000000000-00000.

Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients.

Ther Clin Risk Manag. 2010 Jun 24;6:265-9. doi: 10.2147/tcrm.s11501.